StemMed
|
Year Established:
2008 |
|
|
Website:
stemmedcancer.com/services |
|
|
Headquarters:
Houston, TX, US |
|
|
Company Type:
Small Business (1-10M TTM Revenue) |
StemMed provides state-of-the-art pre-clinical drug testing services using a large panel of patient-derived xenograft (PDX) models of breast and pancreatic cancers. Breast cancer PDX models were developed from an ethnically diverse patient population, and represent all clinically-defined subtypes, including estrogen receptor positive (ER+), HER2+, and “triple-negative” cancers.
| Site | Badges | |
|---|---|---|
| StemMed 7000 Fannin St #210 Houston, TX, 77030 United States | ||
Get started
If your organization has a Scientist.com marketplace, you can log in here to order products and services directly. If you're interested in ordering custom research services from suppliers in the Scientist.com network, book a meeting with our team here. To order products instantly, request access below.